Furthermore, high expression of NFE2L2 is positively correlated with the number of tumor-infiltrating lymphocytes, expression of immune checkpoint molecules and TME in the ER-Positive/HER2-Negative breast cancer [62]. The gene discussed is NFE2L2; the disease is neoplasm.